Morbidity and Mortality of Patients Submitted to Radical Prostatectomy in a Teaching Hospital

Author(s): Thiago da Silveira Antoniassi, Maria Fernanda W. Facio, Jeronimo Jose Neto, Lais Ferraz de Arruda, Daniel Almeida de Oliveira, Marcio Gatti, Pedro Francisco Arruda, Felipe Azenha Lamônica, Germano José Ferraz de Arruda, Luis César Fava Spessoto, Fernando Nestor Facio Junior

Screening for prostate cancer has contributed to an increase in the diagnosis of tumors, probably of moderately differentiated tumors and consequent reduction in the mortality rate. Radical prostatectomy surgery (RPT), along with radiotherapy, brachytherapy, and in some selected cases, active surveillance, is considered the gold standard in the treatment of localized adenocarcinoma of the prostate. The aim of this study was to evaluate the complications of patients undergoing RPT in Hospital de Base São José do Rio Preto. A retrospective study was carried out in 78 patients through a review of patient records between January 2005 and December 2010. Descriptive statistical analysis was used. Of the 78 patients included in this study, 71 had complications related to the surgical procedure. Common morbidities included erectile dysfunction (55.1%) and urinary incontinence (44.8%). Complications mainly occurred in patients older than 70 years (49%). The mortality rate due to postoperative complications was 1.2%. Post-operative complication rates in this study are consistent with previous studies although the mortality rate was slightly higher may reflect the experience of the surgeons who performed the procedure.

Prostate cancer, Radical prostatectomy, Morbidity, Mortality

1. Roach M 3rd, Weinberg V, Sandler H, Thompson I. Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score? Cancer 2007; 109:213.
2. Ries LAG, Eisner, MP, Kosary, CL, et al. SEER Cancer Statistics Review, 1973-1999. National Cancer Institute, Bethesda, MD, 2002.
3. Jarosek SL, Virnig BA, Chu H, Elliott SP. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Eur Urol 2015; 67:273.
4. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982;128(3):492-7.
5. Souto CAV, Rhoden EL, De Conti R, Chammas Jr. M, Laste SE, Fornari A ET AL. Urethral catheter removal 7 or 14 days after radical retropubic prostatectomy: clinical implications and complications in a randomized study. Rev Hosp Clin 2004;59(5):262-265.
6. Hisasue S, Takahashi A, Kato R, Shimizu T, Masumori N, Itoh N, et al. Early and late complications of radical retropubic prostatectomy: Experience in a single institution. Jpn J Clin Oncol.2004;34:274–9.
7. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358:1250.
8. Glazener C, Boachie C, Buckley B, Cochran C, Dorey G, Grant A, Hagen S, Kilonzo M, McDonald A, McPherson G, Moore K, N'Dow J, Norrie J, Ramsay C, Vale L. Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): two parallel randomised controlled trials. Health Technol Assess. 2011 Jun;15(24):1-290, iii-iv.
9. Hanchanale VS, McCabe JE, Javlé P. Radical prostatectomy practice in England. Urol J. 2010 Fall;7(4):243-8.
10. Alibhai SM, Leach M, Tomlinson G, et al. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst 2005; 97:1525.
11. Eggener SE, Scardino PT, Walsh PC, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011; 185:869.
12. Defade BP, Carson CC 3rd, Kennelly MJ. Postprostatectomy erectile dysfunction: the role of penile rehabilitation. Rev Urol. 2011;13(1):6-13.